Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
Aschenbrenner, Diane S. MS, RN
Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: email@example.com.
* The label of lenalidomide (Revlimid) now carries a warning that patients taking the drug for multiple myeloma have a heightened risk of new primary cancers.
A new warning has been added to the label of lenalidomide (Revlimid), a drug used in treating multiple myeloma. Various clinical trials have indicated that there is an increased risk that the patient will develop new types of cancer after treatment with lenalidomide. Information about this risk has been added to the label and to the patient medication guide. The Food and Drug Administration (FDA) isn't recommending delaying, modifying, or restricting the use of lenalidomide, but health care professionals should assess patients receiving lenalidomide and discuss this risk with them. Adverse effects from lenalidomide should be reported to the FDA MedWatch Safety Information and Adverse Event Reporting Program at www.fda.gov/MedWatch/report.htm.
© 2012 Lippincott Williams & Wilkins, Inc.
Colleague's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at AJN The American Journal of Nursing.
Send a copy to your email
Your message has been successfully sent to your colleague.
Some error has occurred while processing your request. Please try after some time.
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Login with your LWW Journals username and password.
Username or Email:
Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.
Link to reset your password has been sent to specified email address.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Save my selection
Article Level Metrics